Gold Nanoparticles Market, By Process, By Application, By End Use, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Gold Nanoparticles market size was valued at US$ 9,203.88 Million in 2025, expanding at a CAGR of 11.1% from 2026 to 2033.

Gold nanoparticles are particles of gold with a size close to 1-100 nm. They have certain optical, electronic, and catalytic properties that are entirely different from bulk gold and can be used in a wide variety of fields, including biomedical imaging, drug delivery, and sensing. The market for gold nanoparticles is expanding at a steady rate due to an increasing market demand for more sophisticated nanomedicine applications, including personalized diagnostics and targeted delivery. In 2025, Cytodiagnostics Inc. focused on providing technology support to facilitate the development of advanced nanomedicine applications in the gold nanoparticle market. They did this by providing their gold nanoparticle-based research platforms, which are predominantly used in assay development and nanoscale biomedical experiments, to gain credibility with the early developers of applications for targeted diagnostics and advanced nanomedicine. Hence, cytodiagnostics is becoming more important in advanced nanomedicine research and targeted diagnostics.

Gold Nanoparticles Market- Market Dynamics

Rising biomedical research funding driving market demand

There has been a rise in grant issuance for increasing biomedical research funding, especially for clinical research and translational science as well as healthcare innovation. Research grant protocols are now more adapted towards infectious and chronic diseases as new threats of diseases emerge demanding rapid scientific advancement. Special importance is given to a stronger research infrastructure and increased funding for young investigators through multi-institutional collaborations.

The biomedical research spending is also projected to boost the Gold Nanoparticles market as a number of investments are made in various applications, such as diagnostics, target drug delivery, and research in therapeutics in the current era, which have the potential of nanotechnology. For example, India has considerably increased investment in biomedical research, according to the Government of India (Department of Biotechnology and Wellcome Trust partnership), with the Biomedical Research Career Programme (BRCP) having a total budget of about USD 180 million in October 2025. In order to consolidate the national research infrastructure by supporting a minimum of 2,000 researchers, including early-stage scientists, post-docs, and clinical researchers from a diverse range of disciplines, this investment is put forth to enhance the biomedical research capabilities and accelerate health care innovations involving gold nanoparticles.

Gold Nanoparticles Market- Segmentation Analysis:

The Global Gold Nanoparticles market is segmented on the basis of Process, Application, End Use, and Region.

Under 'By Process,' chemical synthesis holds a significant share in the Gold Nanoparticles market because it has high usage purity with similarly sized particles and mass-producing scale; hence, it is most widely used in biomedical science, diagnostics, and nanotechnology. For instance, according to Cefic.org, Germany's chemical and pharmaceutical industry generated a turnover of USD 245,000 million, making it the third-largest industrial sector in the country while directly supporting around 479,500 jobs across ~2,100 companies. So this shows heavy dependence on chemical synthesis and the growth of industrial chemical ecosystems.

Based on application focus, imaging holds a prominent share in the gold nanoparticle market due to the broad spectrum of imaging uses, such as biomedical high-resolution imaging, contrast imaging in cancer diagnosis, enhancement in disease detection accuracy and sensitivity, and others. As an example, in 2026 it was identified by the research compiled by Pubs.ACS Nano.Org that the feature of nanoparticle-based imaging systems now represents a coexistent variety of predominant biomedical imaging modalities, including MRI, CT, fluorescence imaging, photoacoustic imaging, etc., but multimodal imaging nanoparticle platforms have already been demonstrated in more than 4 major clinically relevant imaging workflows, including optical, magnetic, X-ray, and hybrid molecular imaging systems. Thus, this supports the growing use of multimodal nanoparticle imaging in advanced biomedical diagnostics.

Gold Nanoparticles Market- Geographical Insights

North America holds a significant share in the Gold Nanoparticles market, owing to the presence of well-developed healthcare facilities and R&D ecosystems within the region. In 2026, as stated by the American Hospital Association (AHA) org., the United States maintains a highly developed healthcare infrastructure comprising approximately 6,100 hospitals nationwide, supported by a large and complex network of care delivery systems. These hospitals collectively operate more than 907,000 staffed hospital beds, enabling large-scale inpatient care capacity across the country. The system handles a significant patient load, with total annual admissions exceeding 35.6 million patients, reflecting the scale and utilization intensity of U.S. hospital services. So, good hospitals and clinics help make sure that new treatments using tiny particles keep being used often.

The Asia Pacific Gold Nanoparticles market is mainly driven by increasing healthcare expenditure in developing Asian countries. For instance, according to the recent World Bank and Global Health Expenditure database of the World Health Organization in Dec 2025, the percentage share of China's current health expenditure contributed by the hospitals and other healthcare establishments remains at 32.2%; as a result, above out-of-pocket payments by Chinese households indicate the heavy burden of day-to-day medical expenses. The net current health expenditure as a percentage of the GDP still remains at 5.9%, demonstrating continued growth in continuing increases in the socioeconomic sectors, which, hence, increase extended healthcare coverage and great efforts to promote and improve the health care infrastructure and also the health service sector at an extensive rate in the country. Hence, money is spent on healthcare; there will be ongoing demand for advanced medical uses of nanotechnology.

UK Gold Nanoparticles Market- Country Insights

The UK's demand for gold nanoparticles is predicted to grow with advances in nanotechnology along with the developed pharmaceutical industry. UK investors are funding more research on nanomedicine, and gold nanoparticles are increasingly used as bioavailable drug delivery agents. For instance, in 2026, according to the Association of the British Pharmaceutical Industry (ABPI), the UK pharmaceutical industry contributed approximately USD 23,760 million in direct gross value added (GVA) to the national economy and invested approximately USD 12,555 million in research and development (R&D). So, when drug companies invest heavily in research and development, it helps create new gold nanoparticle technologies and makes them more widely used.

Gold Nanoparticles Market- Competitive Landscape:

The competitive landscape of the gold nanoparticle industry, measured by the presence of innovative companies like Johnson Matthey, TANAKA Holdings, Merck KGaA, Cytodiagnostics, and Sona Nanotech, is strengthening its market position by developing nanoparticle synthesis, surface functionalization techniques, and high-purity products. The companies are investing in new technologies based on R&D, new personalized products, and a long-term development strategy with the pharma, diagnostics, sensing, and electronics industries. For instance, in May 2025, Sona Nanotech enhanced its gold nanorod-based Targeted Hyperthermia Therapy (THT) platform in terms of supporting clinical progression of biocompatible gold nanorods for cancer tissue treatment efficiency, thereby boosting the commercialization potential of gold nanorods technically and enhancing Sona Nanotech's market position in therapeutic nanotechnology applications. Therefore, high-quality medical nanotechnology creates more business opportunities and enhances competitive market position.

Recent Developments:

In March 2026, Metalor Technologies, a TANAKA Group company, completed the acquisition of Gannon & Scott, a North American precious metals refining and recycling company. The acquisition expands TANAKA's precious metals recycling capabilities, strengthens raw material sourcing channels, and enhances its position in gold-related materials and nanoparticle supply chains.

In May 2025, Merck KGaA announced a strategic partnership with imec to develop next-generation microphysiological systems (MPS)-on-a-chip platforms, leveraging advanced materials, nanoengineering, and AI-enabled research capabilities to improve drug discovery and preclinical testing. The partnership enhances Merck KGaA's position in advanced nanotechnology-enabled life science solutions, accelerates innovation in precision research platforms, and expands opportunities for nanoparticle-based biomedical applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GOLD NANOPARTICLES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Cytodiagnostics Inc.
Goldsol Inc.
BBI Solutions
NanoHybrids Inc.
Nanopartz Inc.
Nanosphere Inc.
Nanostellar Inc.
Solaris Nanosciences Corporation
TANAKA Holdings Co., Ltd.
The Metalor Group
Sigma-Aldrich
Abcam plc
Aurion
Creative Diagnostics
Johnson Matthey Plc
Meliorum Technologies Inc.
Merck KGaA
nanoComposix
Sona Nanotech Inc.
Others

GLOBAL GOLD NANOPARTICLES MARKET, BY PROCESS- MARKET ANALYSIS, 2020 - 2033

Chemical
Physical
Green/Biological Synthesis
Seed-mediated Growth
Continuous Flow and Microfluidic

GLOBAL GOLD NANOPARTICLES MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

Imaging
Targeted Drug Delivery
Proton Therapy
In-vitro Assays
Sensors, Probes
Catalysis
Others

GLOBAL GOLD NANOPARTICLES MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

Pharmaceutical & Healthcare
Chemicals and Catalysts
Energy and Environmental
Electronics and Semiconductors
Personal Care & Cosmetics
Others

GLOBAL GOLD NANOPARTICLES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV6719

1. Gold Nanoparticles Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Gold Nanoparticles Market Snippet by Process
- 2.1.2. Gold Nanoparticles Market Snippet by Application
- 2.1.3. Gold Nanoparticles Market Snippet by End Use
- 2.1.4. Gold Nanoparticles Market Snippet by Country
- 2.1.5. Gold Nanoparticles Market Snippet by Region
2.2. Competitive Insights

3. Gold Nanoparticles Key Market Trends

3.1. Gold Nanoparticles Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Gold Nanoparticles Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Gold Nanoparticles Market Opportunities
3.4. Gold Nanoparticles Market Future Trends

4. Gold Nanoparticles Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Gold Nanoparticles Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Gold Nanoparticles Market Landscape

6.1. Gold Nanoparticles Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Gold Nanoparticles Market - By Process

7.1. Overview
- 7.1.1. Segment Share Analysis, By Process, 2025 & 2033 (%)
- 7.1.2. Chemical
- 7.1.3. Physical
- 7.1.4. Green/Biological Synthesis
- 7.1.5. Seed-mediated Growth
- 7.1.6. Continuous Flow and Microfluidic

8. Gold Nanoparticles Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 8.1.2. Imaging
- 8.1.3. Targeted Drug Delivery
- 8.1.4. Proton Therapy
- 8.1.5. In-vitro Assays
- 8.1.6. Sensors, Probes
- 8.1.7. Catalysis
- 8.1.8. Others

9. Gold Nanoparticles Market - By End Use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
- 9.1.2. Pharmaceutical & Healthcare
- 9.1.3. Chemicals and Catalysts
- 9.1.4. Energy and Environmental
- 9.1.5. Electronics and Semiconductors
- 9.1.6. Personal Care & Cosmetics
- 9.1.7. Others

10. Gold Nanoparticles Market - By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Gold Nanoparticles Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Gold Nanoparticles Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.16. Denmark
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.16.3. Denmark Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.16.5. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.3.17. Rest of Europe
  - 10.3.17.1. Overview
  - 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.17.3. Rest of the Europe Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.17.5. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Gold Nanoparticles Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.15. Taiwan
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.15.3. Taiwan Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.15.5. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.16. Vietnam
  - 10.4.16.1. Overview
  - 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.16.3. Vietnam Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.16.5. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.4.17. Rest of APAC
  - 10.4.17.1. Overview
  - 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.17.3. Rest of APAC Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.17.5. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Gold Nanoparticles Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Gold Nanoparticles Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.13. Iran
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.13.3. Iran Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.13.5. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.14. Qatar
  - 10.6.14.1. Overview
  - 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.14.3. Qatar Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.14.5. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 10.6.15. Rest of MEA
  - 10.6.15.1. Overview
  - 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.15.3. Rest of MEA Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
  - 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.15.5. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Gold Nanoparticles Industry

11.1. Competitive Benchmarking
- 11.1.1. Competitive Dashboard
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Cytodiagnostics Inc.
- 11.2.2. Goldsol Inc.
- 11.2.3. BBI Solutions
- 11.2.4. NanoHybrids Inc.
- 11.2.5. Nanopartz Inc.
- 11.2.6. Nanosphere Inc.
- 11.2.7. Nanostellar Inc.
- 11.2.8. Solaris Nanosciences Corporation
- 11.2.9. TANAKA Holdings Co., Ltd.
- 11.2.10. The Metalor Group
- 11.2.11. Sigma-Aldrich
- 11.2.12. Abcam plc
- 11.2.13. Aurion
- 11.2.14. Creative Diagnostics
- 11.2.15. Johnson Matthey Plc
- 11.2.16. Meliorum Technologies Inc.
- 11.2.17. Merck KGaA
- 11.2.18. nanoComposix
- 11.2.19. Sona Nanotech Inc.
- 11.2.20. Others

12. 360 Degree AnalystView

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us